When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
This disruptive medtech player in oncology is up >7x since I started covering it on Seeking Alpha in 2016 (when it was trading at $7.76/share). I wrote the title in my initiation article as 'NovoCure's TTFields Therapy Could Become The Standard Adjunct Therapy In Various Solid Tumors'. Over the past 4 years, the company has shown significant pipeline progress in making my title closer to reality.
I took advantage of the recent pullback in the stock off 52-week high to re-enter a long core position. My key interest is the